machineMD AG

machineMD AG is a medical device company founded at the University Hospital of Bern, Switzerland, specializing in non-invasive neuroophthalmological diagnostic equipment. The company develops neos®, a proprietary neurophthalmoscope platform designed for automated, quantitative assessment of eye movements, pupils, and visual fields. neos® enables standardized, objective measurement of neuroophthalmological function across primary, secondary, and tertiary care settings, reducing operator variability and extending specialist-level diagnostic capability to underserved clinical environments. The platform incorporates quantitative pupillometry and oculometric analysis with demonstrated clinical applications across neurological and ophthalmological indications including multiple sclerosis, myasthenia gravis, Parkinson's disease, Alzheimer's disease, Huntington's disease, stroke, traumatic brain injury, age-related macular degeneration, and other neurodegenerative and neuro-ophthalmological conditions. machineMD operates facilities in Bern, Switzerland (headquarters at Weyermannsstrasse 36, 3008 Bern) and Cambridge, Massachusetts (1 Broadway, Cambridge, MA 02142). The company maintains active clinical partnerships with major Swiss academic hospitals including University Hospital Lucerne (LUKS), Inselspital Bern, and Universitätsspital Zürich, and international collaborations. Regulatory pathway and specific FDA/CE certification status not detailed on accessible site content.